| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Reduced Metabolites Involves Mitogen-Activated Protein Kinase
Department of Neuroscience, Albert Einstein College of Medicine (O.G.-F., J.S., A.M.E.), Bronx, New York 10461; Centro de Investigación en Reproducción Animal, Centro de Investigacion y de Estudios Avanzados-Universidad Autonoma de Tlaxcala (O.G.-F.), Tlaxcala 90140, Mexico; and Departamento de Biología, Facultad de Quimica, Universidad Nacional Autonoma de Mexico (I.C.-A.), Coyoacan 04510, Mexico
Address all correspondence and requests for reprints to: Dr. Anne M. Etgen, Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: etgen{at}aecom.yu.edu.
Progesterone (P) and its ring A-reduced metabolites regulate sexual behavior in ovariectomized, estrogen-primed female rats when they are administered intracerebrally and systemically. The present study tested the hypothesis that the MAPK pathway participates in P facilitation and sequential inhibition of sexual behavior. The role of MAPK in lordosis facilitation by two ring A-reduced metabolites of P, 5
-dihydroprogesterone (5-DHP) and 5,3-pregnanolone (5,3-Pgl), was also assessed. In Experiment 1, the MAPK inhibitor PD98059 was infused intracerebroventricularly before progestin administration. Lordosis behavior induced by P, 5-DHP, and 5,3-Pgl was abolished 2 h after progestin ad-ministration by PD98059. P and 5,3-Pgl facilitation of proceptive behaviors was also decreased by the MAPK inhibitor. Experiment 2 examined the effects of MAPK inhibition on P sequential inhibition. Estrogen-primed females received intracerebroventricular infusions of PD98059 or vehicle 30 min before systemic administration of P and were tested for lordosis 4 h later. Animals received a second injection of P 24 h later and were retested for lordosis. The MAPK inhibitor blocked both lordosis facilitation and sequential inhibition produced by systemic administration of P. Because cGMP can also facilitate lordosis behavior, and cGMP-dependent protein kinase can activate MAPK, experiment 3 determined whether interference with MAPK would affect cGMP enhancement of lordosis. The icv infusion of PD98059 significantly inhibited lordosis behavior induced by 8-bromo-cGMP, a cell-permeable cGMP analog, at both 2 and 4 h. These data support the hypothesis that the MAPK pathway is involved in lordosis regulation by P and some of its ring A-reduced metabolites as well as by the second messenger, cGMP.
This article has been cited by other articles:
 |
|
 |
|
  J. J Paris and C. A Frye Estrous cycle, pregnancy, and parity enhance performance of rats in object recognition or object placement tasks Reproduction, July 1, 2008; 136(1): 105 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Singru, E. Sanchez, R. Acharya, C. Fekete, and R. M. Lechan Mitogen-Activated Protein Kinase Contributes to Lipopolysaccharide-Induced Activation of Corticotropin-Releasing Hormone Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus Endocrinology, May 1, 2008; 149(5): 2283 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jover-Mengual, R. S. Zukin, and A. M. Etgen MAPK Signaling Is Critical to Estradiol Protection of CA1 Neurons in Global Ischemia Endocrinology, March 1, 2007; 148(3): 1131 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wu, M. J. Glucksman, J. L. Roberts, and S. K. Mani Facilitation of Lordosis in Rats by a Metabolite of Luteinizing Hormone Releasing Hormone Endocrinology, May 1, 2006; 147(5): 2544 - 2549. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
